Abstract

BackgroundDetection of lymphovascular space invasion (LVSI) in early cervical cancer (CC) is challenging. To date, no standard clinical markers or screening tests have been used to detect LVSI preoperatively. Therefore, non-invasive risk stratification tools are highly desirable.ObjectiveTo train and validate a multi-parametric magnetic resonance imaging (mpMRI)-based radiomics model to detect LVSI in patients with CC and investigate its potential as a complementary tool to enhance the efficiency of risk assessment strategies.Materials and MethodsThe model was developed from the tumor volume of interest (VOI) of 125 patients with CC. A total of 1037 radiomics features obtained from conventional magnetic resonance imaging (MRI), including a small field-of-view (sFOV) high-resolution (HR)-T2-weighted MRI (T2WI), apparent diffusion coefficient (ADC), T2WI, fat-suppressed (FS)-T2WI, as well as axial and sagittal contrast-enhanced T1-weighted MRI (T1c). We conducted a radiomics-based characterization of each tumor region using pretreatment image data. Feature selection was performed using the least absolute shrinkage and selection operator method on the training set. The predictive performance was compared with single variates (clinical data and single-layer radiomics signatures) analyzed using a receiver operating characteristic (ROC) curve. Three-fold cross-validation performed 20 times was used to evaluate the accuracy of the trained classifiers and the stability of the selected features. The models were validated by using a validation set.ResultsFeature selection extracted the six most important features (3 from sFOV HR-T2WI, 1 T2WI, 1 FS-T2WI, and 1 T1c) for model construction. The mpMRI-combined radiomics model (area under the curve [AUC]: 0.940) reached a significantly higher performance (better than the clinical parameters [AUC: 0.730]), including any single-layer model using sFOV HR-T2WI (AUC: 0.840), T2WI (AUC: 0.770), FS-T2WI (AUC: 0.710), ADC maps (AUC: 0.650), sagittal, and axial T1c values (AUC: 0.710, 0.680) in the validation set.ConclusionBiomarkers using multi-parametric radiomics features derived from preoperative MR images could predict LVSI in patients with CC.

Highlights

  • Cervical cancer (CC) is the fourth most frequently diagnosed cancer worldwide, with an increasing incidence rate, high mortality rate, and a younger age of onset [1]

  • A total of 1037 radiomics features obtained from conventional magnetic resonance imaging (MRI), including a small field-of-view high-resolution (HR)-T2-weighted MRI (T2WI), apparent diffusion coefficient (ADC), T2WI, fat-suppressed (FS)-T2WI, as well as axial and sagittal contrast-enhanced T1-weighted MRI (T1c)

  • Biomarkers using multi-parametric radiomics features derived from preoperative MR images could predict Lymphovascular space invasion (LVSI) in patients with CC

Read more

Summary

Introduction

Cervical cancer (CC) is the fourth most frequently diagnosed cancer worldwide, with an increasing incidence rate, high mortality rate, and a younger age of onset [1]. Lymphovascular space invasion (LVSI) refers to the presence of cancer cell clusters in the vascular and/or lymphatic lumen [2]. LVSI increases the risk of lymph node metastases (LNM), which is an independent high-risk factor for tumor recurrence and influences treatment methods [3,4,5]. Satellite LVSIs significantly increase the risk of death and recurrence [7]. It is challenging to determine the decisive characteristics of LVSI in clinically relevant biomarkers due to intralesional heterogeneity, extra time delays, and high testing costs. A reformative, non-invasive, real-time, and cost-efficient preoperative test method for risk identification will have a considerable clinical impact on women with CC. Detection of lymphovascular space invasion (LVSI) in early cervical cancer (CC) is challenging. No standard clinical markers or screening tests have been used to detect LVSI preoperatively.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call